MPS Powered by Eureka

Forgot your password?

To find the most relevant journal, please insert appropriate keyword to facilitate search.

 

Type keyword

Search Results: CDTH



Download Flyer

Current Drug Therapy

Start Submission

ISSN: 1574-8855 (Print)
eISSN: 2212-3903 (Online)

Journal
Impact Factor :

0.3

Scopus
CiteScore:

1.3

Aims and Scope:Current Drug Therapy publishes high-quality original research articles, full-length/mini reviews, and guest-edited thematic issues covering a wide range of topics in drug science, therapy, and medical advancements. The journal encompasses research on:

  • Drug discovery, development, and delivery
  • Clinical trials and real-world evidence studies
  • Pharmacology, toxicology, and drug safety
  • Targeted and biologic therapies, including immunotherapy
  • Traditional, alternative, and regenerative medicine
  • Personalized medicine, pharmacogenomics, and precision therapies
  • Artificial intelligence and big data in drug research
  • Regulatory science, drug approval processes, and public health perspectives
  • Vaccine development, immunization strategies, and epidemiology
  • Drug repurposing, repositioning, and novel therapeutic approaches
  • Nanotechnology in Drug Delivery
  • Gene and Cell Therapies
  • Antimicrobial Resistance and Novel Antibiotics
  • Neuropharmacology and Psychiatric Drug Development
  • Pediatric and Geriatric Pharmacology
The journal serves as an essential resource for researchers, clinicians, and industry professionals working in drug science, healthcare, and therapeutic innovations.

Current Drug Therapy is an international, peer-reviewed journal on all the latest advances in drug therapy and drug clinical trial studies, published monthly (print & online) by Bentham Science Publishers.

Editor-in-Chief:


Stefano Palomba Department of Obstetrics & Gynecology
University of Magna Graecia of Catanzaro
Catanzaro
Italy

Indexed in:


Scopus, ESCI, JCR... View all

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2025
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)

The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which play pivotal roles in the pathogenesis and progression of CKD. Furthermore, it will encompass an in-depth examination of innovative treatment modalities, including gene therapy, immunotherapy,... see more

Impact Factor: 0.3
Guest Editor(s): Ronald St-Louis
Start Submission